Clinical Trials Logo

Filter by:
NCT ID: NCT04338334 Recruiting - Clinical trials for Axillary Web Syndrome

Effectiveness of Cohesive Bandage on Axillary Web Syndrome After

CBaws
Start date: January 10, 2019
Phase: N/A
Study type: Interventional

Objective: To determine the effectiveness of cohesive bandage on the axillary web syndrome in improving pain, reducing swelling and increasing mobility and functionality of the shoulder. Design: randomized single-blinded controlled trial. Follow-up: five physical therapy assessments: pre-intervention; post-intervention, 3 and 6 months post-intervention post-intervention. Participants: 90 consecutive women diagnosed with axillary web syndrome after undergoing unilateral breast cancer surgery with ALND or SLND at the Prıíncipe de Asturias Hospital in Alcalà de Henares, Madrid (Spain). Randomization: women will be randomly assigned to two groups by EpiData 3.1 software. Interventions: Control group: Physical Therapy composed of manual lymph-drainage technique in axilla, and proximal ipsilateral arm, specific thumb manual lymph-drainage on the taut cords to make them gradually more flexible, in conjunction with progressive active arm therapeutic exercises; Intervention group: progressive active arm therapeutic exercises with cohesive bandage.

NCT ID: NCT04337528 Recruiting - Sacroiliac Disorder Clinical Trials

Osteopathic Thrust and Muscle-energy Manipulations on Sacroiliac Joint Dysfunction

Start date: January 7, 2020
Phase: N/A
Study type: Interventional

This study assesses the effect of manipulative techniques of thrust and muscle-energy over the sacroiliac joint on plantar foot support, weight distribution in the lower limbs and balance in amateur runners with sacroiliac dysfunction. participants will be randomly assigned to one of 3 manipulations (i.e., intervention): thrust, muscle-energy or placebo.

NCT ID: NCT04337450 Recruiting - HIV Infections Clinical Trials

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

D3 (Penta21)
Start date: April 22, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This study aims to find out whether treating children and young people living with HIV with two anti HIV medicines, dolutegravir and lamivudine, is safe and as effective as the three-medicine anti-HIV treatments currently used in routine practice.

NCT ID: NCT04337398 Recruiting - Exercise Therapy Clinical Trials

Exercise in Severe Mental Illness. The PsychiActive Project 2.0

Start date: April 20, 2020
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial is to study the feasibility, adherence and effects of two exercise interventions on body weight, body composition, anthropometric and fasting blood measures, physical fitness, quality of life, and lifestyle habits in patients with severe mental illness.

NCT ID: NCT04336722 Recruiting - Biliary Atresia Clinical Trials

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

Start date: July 8, 2020
Phase: Phase 3
Study type: Interventional

Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy.

NCT ID: NCT04336241 Recruiting - Cancer Clinical Trials

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

Start date: October 17, 2019
Phase: Phase 1
Study type: Interventional

RP2-001-18 is a Phase 1, multicenter, open label, single agent dose escalation and combination treatment study of RP2 in adult subjects with advanced solid tumors, to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), as well as to evaluate preliminary efficacy.

NCT ID: NCT04335032 Recruiting - SARS-CoV-2 Clinical Trials

EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)

Start date: January 8, 2021
Phase: Phase 3
Study type: Interventional

This is an double-blind, randomized, placebo controlled phase III study in hospitalized subjects with confirmed SARS-CoV-2.

NCT ID: NCT04333381 Recruiting - Clinical trials for Myocardial Infarction

Early Diagnosis of Acute Myocardial Infarction: Impact of an Educational and Organizational Intervention

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The hypothesis is that an educational program aimed at emergency nurses and the implementation of measures at the organizational level reduce the time between arrival at the emergency room and the opening of the artery or balloon by 40% in patients attending for acute myocardial infarction.

NCT ID: NCT04332094 Recruiting - COVID-19 Clinical Trials

Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)

TOCOVID
Start date: April 2, 2020
Phase: Phase 2
Study type: Interventional

COVID-19 is a respiratory disease caused by the new coronavirus (SARS-CoV-2) and causes considerable morbidity and mortality. Currently, there is no vaccine or therapeutic agent to prevent and treat a SARS-CoV-2 infection. This clinical trial is designed to evaluate the use of Tocilizumab in combination with hydroxychloroquine and azithromycin for the treatment of hospitalized adult patients with COVID-19.

NCT ID: NCT04331821 Recruiting - Sleep Apnea Clinical Trials

READ-ASV Registry - Phase II

READ-ASV
Start date: May 1, 2019
Phase:
Study type: Observational

The READ-ASV Registry (short name) will investigate the use of Adaptive Servo-Ventilation in non-heart failure conditions. The purpose is to examine the effects of ASV on quality of life, daytime symptoms and sleep, to describe usage patterns of ASV with regards to patient characteristics and to document adverse events related to therapy for a therapy safety analysis.